Development of a Wine By‐Product‐Based Beverage and Study of Its Potential to Postprandial Glycemia Regulation in Healthy Individuals: A Proof of Concept Study
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von María-José Motilva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Ciencias de la Vid y del Vino-ICVV (Consejo Superior de Investigaciones Científicas-CSIC, Universidad de La Rioja-UR, Gobierno de La Rio…. Hauptthemen laut MEDLINE: Wine, Blood Glucose. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONICET for JM's international stage at the ICVV, European FEADER funds, the Ministry of Agriculture and Food of Spain and the Government of La Rioja, PDR "plusPRODUCT: By-product valorization and development of the Circular Economy in the Agrifood Industry".
Abstract (Originalsprache)
Aligned with the principles of the circular bioeconomy, this study explores the use of winemaking by‐products as a source of bioactive phenolic compounds. Skins and seeds from Tempranillo and Graciano grapevine varieties were conditioned to prepare a phenolic‐rich beverage. To study its hypoglycemic properties, a pilot trial was conducted to evaluate postprandial glycemia after the intake of the wine by‐product‐based beverage (WBB). The postprandial glycemia of 10 healthy adults was measured after the intake of: (i) water + sugar solution, (ii) WBB + sugar solution, and (iii) WBB + water. In parallel to blood glucose measurement, blood samples were also collected using dried blood spot cards to determine the phenolic metabolites by UHPLC‐QqQ‐MS/MS. Although blood glucose levels tended to decrease after WBB intervention, these changes were not statistically significant related to the interindividual variability. The volunteers showing a reduction in blood glucose were classified as “responders”, and those who showed no changes were classified as “non‐responders”. Wine by‐products can be effectively used in functional beverages formulation to increase bioactive compound content and manage postprandial glucose in some individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Ciencias de la Vid y del Vino-ICVV (Consejo Superior de Investigaciones Científicas-CSIC, Universidad de La Rioja-UR, Gobierno de La Rioja), Finca La Grajera, Logroño, Spain.
- Antioxidants Research Group, Food Technology Department, Agrotecnio-RECERCA Center, University of Lleida, Lleida, Spain.
- Faculty of Health Sciences, Universidad de La Rioja, Logroño, Spain.
- Fisicoquímica, Facultad de Farmacia y Bioquímica-IBIMOL, Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
ORCID-Profile: Juana I Mosele
Förderung
- CONICET for JM's international stage at the ICVV
- European FEADER funds, the Ministry of Agriculture and Food of Spain and the Government of La Rioja
- PDR "plusPRODUCT: By-product valorization and development of the Circular Economy in the Agrifood Industry"
Zitieren
APA
Motilva, M. J., Yuste, S., & Mosele, J. I. (2025). Development of a Wine By‐Product‐Based Beverage and Study of Its Potential to Postprandial Glycemia Regulation in Healthy Individuals: A Proof of Concept Study. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70128
Vancouver
Motilva MJ, Yuste S, Mosele JI. Development of a Wine By‐Product‐Based Beverage and Study of Its Potential to Postprandial Glycemia Regulation in Healthy Individuals: A Proof of Concept Study. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70128
BibTeX
@article{Motilva2025,
author = {Motilva, María-José and Yuste, Silvia and Mosele, Juana I},
title = {Development of a Wine By‐Product‐Based Beverage and Study of Its Potential to Postprandial Glycemia Regulation in Healthy Individuals: A Proof of Concept Study},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70128}
}
EUVIMED